OOD-GraphLLM: Graph Large Language Model for Out-of-Distribution Generalized Drug Synergy Prediction
arXiv:2605.30247v1 Announce Type: new Abstract: Drug synergy prediction (DSP) aims to identify efficacious drug combinations under various cellular contexts with different targets. However, the continual emergence of novel compounds results in variations in molecular scaffolds and sizes, causing drug synergy data to exhibit out-of-distribution (O.O.D.) shifts with respect to topological structure. Existing works rely on in-distribution (I.D.) assumption, failing to handle the O.O.D. shifts. To solve this problem, we study out-of-distribution generalized drug synergy prediction through a graph
The accelerating pace of AI development, particularly in graph neural networks and large language models, is enabling new approaches to complex scientific problems like drug synergy prediction.
Improving drug synergy prediction can significantly accelerate drug discovery and development, leading to more effective treatments and personalized medicine strategies.
This research introduces a novel methodology for predicting drug synergy that can handle out-of-distribution data, addressing a key limitation of existing models and potentially broadening the applicability of AI in pharmacology.
- · Pharmaceutical companies
- · AI-driven drug discovery platforms
- · Patients with complex diseases
- · Computational biologists
- · Traditional drug discovery methods
- · Research groups reliant on in-distribution assumptions
More efficient identification of combined drug therapies for various diseases.
Reduced R&D costs and accelerated time-to-market for new drug combinations.
The development of highly personalized multi-drug cocktails based on individual patient genomic and proteomic profiles.
This signal links to a primary source. Continuum Brief monitors and indexes it as part of the live intelligence stream — we do not republish source content.
Read at arXiv cs.LG